In vivo tumor imaging using a near-infrared-labeled endostatin molecule

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 2, 2004, Pages 536-541

  Citrin, Deborah ^a   Scott, Tamalee ^a   Sproull, Mary ^a   Menard, Cynthia ^a   Tofilon, Philip J ^a   Camphausen, Kevin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Angiogenesis; Endostatin; Murine; Near infrared

Indexed keywords

CHARGE COUPLED DEVICES; FILTRATION; GELS; MEDICAL IMAGING; PATIENT MONITORING; PROTEINS; RADIOTHERAPY; TUMORS;

ANGIOGENESIS;

ONCOLOGY;

DYE; ENDOSTATIN; GREEN FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; GEL FILTRATION; IMAGING SYSTEM; INFRARED RADIATION; LABELING INDEX; LIGHT EXPOSURE; MALE; MOLECULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEDATION; TUMOR; TUMOR LOCALIZATION;

EID: 0942300640     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.09.068     Document Type: Conference Paper

References (21)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 82:1989;4-6.
2. Holmgren L., O'Reilly M.S., Folkman J. Dormancy of micrometastases Balanced proliferation and apoptosis in the presence of angiogenesis suppression . Nat Med. 1:1995;149-153.
3. Fang J., Shing Y., Wiederschain D., et al. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci. 97:2000;3884-3889.
4. Ausprunk D., Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res. 14:1977;53-65.
5. Sipkins D., Cheresh D., Kazemi M., et al. Detection of tumor angiogenesis in vivo by alphaV-beta3 targeted magnetic resonance imaging. Nat Med. 4:1998;623-626.
6. Denekamp J. Endothelial cell proliferation as a novel approach to targeting tumour therapy. Br J Cancer. 45:1982;136-141.
7. Denekamp J. Vascular attack as a therapeutic strategy for cancer. Cancer Metast Rev. 9:1990;267-282.
8. Tatum J., Hoffman J. Role of imaging in clinical trials of antiangiogenesis therapy in oncology. Acad Radiol. 7:2000;798-799.
9. Cheng W.-F., Lee C.-N., Chu J.-S., et al. Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma. Cancer. 85:1999;651-657.
10. Miles K. Tumor angiogenesis and its relation to contrast enhancement on computed tomography A review . Eur J Radiol. 30:1999;198-205.
11. Weissleder R., Tung C., Mahmood U., et al. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol. 17:1999;375-378.
12. Tung C.-H., Mahmood U., Bredow S., et al. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res. 60:2000;4953-4958.
13. Sasaki T., Larsson H., Kreuger J., et al. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J. 18:1999;6240-6248.
14. Karumanchi S., Jha V., Ramchandran R., et al. Cell surface glypicans are low-affinity endostatin receptors. Mol Cell. 7:2001;811-822.
15. Kim Y., Hwang S., Kim Y., et al. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J Biol Chem. 31:2002;27872-27879.
16. Berger A., Feldman A., Gnant M., et al. The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing. J Surg Res. 91:2000;26-31.
17. Yang D., Kim K., Schechter N., et al. Assessment of antiangiogenic effect using 99mTc-EC-endostatin. Cancer Biotherapeut Radiopharmaceut. 17:2002;233-245.
18. O'Reilly M., Holmgren L., Shing Y., et al. Angiostatin A novel angiogenesis inhibitor that mediates the suppression of metastases by Lewis lung carcinoma . Cell. 79:1994;315-328.
19. Camphausen K., Menard C. Angiogenesis inhibitors and radiotherapy of primary tumors. Exp Opin Biol Ther. 2:2002;477-481.
20. Hanna N., Seetharam S., Mauceri H., et al. Antitumor interaction of short-course endostatin and ionizing radiation. Cancer J. 6:2000;287-293.
21. Ergun A., Camphausen K., Wein L. Optimal scheduling of radiotherapy and angiogenic inhibitors. Bull Mathemat Biol. 65:2003;407-424.